Streetbeat News

Regulatory

NSPR

InspireMD, Inc. (NASDAQ:NSPR) presented 30-day results from the C-GUARDIANS U.S. Investigational Device Exemption (IDE) clinical trial at the Vascular InterVentional Advances (VIVA) meeting. The trial evaluated the safety and efficacy of the CGuard™ Carotid Stent System. The follow-up data supports the safety of the C-Guard EPS stent, with a low rate of major adverse events observed through 30 days. InspireMD anticipates reporting primary endpoint results from C-GUARDIANS in the second half of 2024 that may support a Premarket Approval (PMA) application.

Portfolio Pulse from Benzinga Newsdesk

November 01, 2023 | 6:26 pm

AMZN

Amazon.com, Inc. (NASDAQ:AMZN) shares are trading higher after reporting better-than-expected Q3 financial results and strong Q4 guidance. The company's Q3 revenue rose by 13% to $143.1 billion, beating expectations. Earnings per share were 94 cents, up from 28 cents YoY. AWS sales reached $23.1 billion, marking a 12% YoY increase. The upcoming Federal Reserve decision on interest rates could impact Amazon's sales and investor sentiment.

Portfolio Pulse from Henry Khederian

November 01, 2023 | 6:20 pm

FRBK

The Federal Deposit Insurance Corp. (FDIC) has suspended the auction process for Republic First Bancorp Inc. after the bank struck a deal to raise money from investors. The FDIC had sought bids for Republic First last week. The bank, which delisted from the Nasdaq in August, announced it would raise $35 million from a group of investors including George E. Norcross III, Gregory B. Braca and Philip A. Norcross.

Portfolio Pulse from Benzinga Newsdesk

November 01, 2023 | 6:18 pm

QQQ

SPY

TLT

UUP

The Federal Reserve has decided to maintain interest rates at 5.25%-5.5% during its November meeting. The Fed reaffirmed its commitment to achieving a 2% inflation target and will continue to monitor economic data and outlook. The Fed acknowledges that inflation remains elevated and tighter credit conditions are likely to exert downward pressure on economic activity. The market showed little movement following the announcement, with the U.S. dollar index, tracked by the Invesco DB USD Index Bullish Fund ETF (UUP), seeing a marginal 0.1% decline. The iShares 20+ Year Treasury Bond ETF (TLT) recorded a 1.3% increase, while the SPDR S&P 500 ETF Trust (SPY) posted a 0.4% gain and the Invesco QQQ Trust (QQQ) surged by 0.8%.

Portfolio Pulse from Piero Cingari

November 01, 2023 | 6:14 pm

TGTX

TG Therapeutics reported Q3 FY23 Briumvi sales of $25.1 million, up from $16 million in Q2 FY23. Total net product revenue since launch is approximately $48.9 million. Overall revenues reached $165.8 million, including a license revenue of $140 million from Neuraxpharm. The company reported a Q3 EPS of 73 cents compared to a loss of 26 cents a year ago. The FDA approved Briumvi in January 2023 for relapsing forms of multiple sclerosis. The company's cash position stood at $229.2 million. TGTX shares were up 31.5% at $10.16.

Portfolio Pulse from Vandana Singh

November 01, 2023 | 6:11 pm

SPY

Traders of short-term U.S. interest rates have increased their bets that the Federal Reserve will start cutting rates by June 2024. This could potentially impact the performance of the SPY ETF, which tracks the S&P 500 index.

Portfolio Pulse from Benzinga Newsdesk

November 01, 2023 | 6:04 pm

SPY

The Federal Reserve has announced that it is prepared to adjust its policy stance 'as appropriate' if risks emerge to achieving its goals. The Fed will continue bond holding reductions as previously planned.

Portfolio Pulse from Benzinga Newsdesk

November 01, 2023 | 6:02 pm

SPY

The Federal Open Market Committee (FOMC) reported that the economy expanded at a 'strong' pace in Q3. However, it warned that higher long-term interest rates could negatively impact economic activity, hiring, and inflation. Job gains have moderated since earlier in the year, and inflation remains elevated. The committee voted unanimously for the Fed funds rate action.

Portfolio Pulse from Benzinga Newsdesk

November 01, 2023 | 6:01 pm

SPY

The Federal Open Market Committee (FOMC) has decided to maintain the target range for the federal funds rate at 5-1/4 to 5-1/2 percent. The Committee is committed to returning inflation to its 2 percent objective. The U.S. banking system is sound and resilient, but tighter financial and credit conditions for households and businesses are likely to impact economic activity, hiring, and inflation.

Portfolio Pulse from Benzinga Newsdesk

November 01, 2023 | 6:00 pm

SPY

The Federal Reserve has decided to leave the key overnight interest rate unchanged.

Portfolio Pulse from Benzinga Newsdesk

November 01, 2023 | 6:00 pm